Hye-Jung Kim, PH.D.

Hye-Jung Kim, PH.D.

2011-2012
Testing a Novel Way to Treat Arthritis
Image

Hye-Jung Kim, PH.D.
Dana-Farber Cancer Institute
Boston, Massachusetts

CD8+ Treg suppression of collagen-induced arthritis

Autoimmune diseases, including Rheumatoid Arthritis (RA), occur when the immune system mistakenly attacks the body’s own tissues. This complex system of cells and antibodies normally destroys “invaders” such as viruses and infections. Unfortunately, RA patients have immune cells and antibodies in their blood that attack their own tissues.

In this project, Dr. Kim evaluates the ability of a recently identified cell population, termed CD8+ regulatory T cells, to suppress or block RA progression. Using novel strategies, Dr. Kim will examine the potential therapeutic effects of this cell-based treatment to ameliorate or prevent RA.

ANRF
Article Author
Arthritis National Research Foundation
arthritisresearch@curearthritis.org

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

No Comments

Sorry, the comment form is closed at this time.